Guangxian You

Taizhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Anlotinib + Toripalimab maintenance in Extensive-Stage small cell lung Cancer: Clinical efficacy and preclinical mechanism of anlotinib-induced neuroendocrine differentiation Suppression via Notch1.

Anlotinib + Toripalimab maintenance in Extensive-Stage small cell lung Cancer: Clinical efficacy and preclinical mechanism of anlotinib-induced neuroendocrine differentiation Suppression via Notch1.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 01, 2025

Expression and clinical significance of ERBB4 in gastric cancer.

Expression and clinical significance of ERBB4 in gastric cancer.

Journal: Journal of gastrointestinal oncology

Published: August 18, 2025

Association of socioeconomic status and nine modifiable lifestyle factors on esophageal cancer risk in European and East Asian populations - Evidence from a comprehensive Mendelian randomization study.

Association of socioeconomic status and nine modifiable lifestyle factors on esophageal cancer risk in European and East Asian populations - Evidence from a comprehensive Mendelian randomization study.

Journal: Nutricion hospitalaria

Published: June 12, 2025

Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study.

Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study.

Journal: Translational lung cancer research

Published: December 04, 2024

Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.

Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.

Journal: Neoplasma

Published: October 14, 2024

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 30, 2024

TMEM33, an oncogene regulated by miR-214-3p, promotes the progression of lung adenocarcinoma through the Wnt/β-catenin signaling pathway.

TMEM33, an oncogene regulated by miR-214-3p, promotes the progression of lung adenocarcinoma through the Wnt/β-catenin signaling pathway.

Journal: Oncology research

Published: March 22, 2024

The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer.

The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer.

Journal: Translational cancer research

Published: December 04, 2023

Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.

Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.

Journal: Neoplasma

Published: November 04, 2023

Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91].

Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91].

Journal: Biochemical and biophysical research communications

Published: April 12, 2021

TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.

TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.

Journal: Biochemical and biophysical research communications

Published: January 07, 2021

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.

Journal: World journal of surgical oncology

Published: July 16, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026